Prestige Consumer Healthcare (NYSE:PBH) Given “Hold” Rating at Jefferies Financial Group

Jefferies Financial Group reissued their hold rating on shares of Prestige Consumer Healthcare (NYSE:PBH) in a report released on Tuesday, Benzinga reports. Jefferies Financial Group currently has a $76.00 price target on the stock, up from their prior price target of $70.00.

Separately, DA Davidson boosted their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a buy rating in a research note on Wednesday, August 28th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of Moderate Buy and a consensus target price of $94.20.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE:PBH opened at $71.32 on Tuesday. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The business’s 50 day moving average price is $71.21 and its 200-day moving average price is $69.65. The firm has a market capitalization of $3.54 billion, a PE ratio of 17.10, a P/E/G ratio of 2.04 and a beta of 0.48. Prestige Consumer Healthcare has a 1 year low of $56.34 and a 1 year high of $75.80.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.90 EPS for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The firm had revenue of $267.10 million for the quarter, compared to the consensus estimate of $260.54 million. During the same quarter last year, the business posted $1.06 earnings per share. The firm’s revenue was down 4.4% compared to the same quarter last year. As a group, equities research analysts expect that Prestige Consumer Healthcare will post 4.42 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of PBH. Principal Securities Inc. acquired a new stake in Prestige Consumer Healthcare in the fourth quarter valued at $29,000. Vanguard Personalized Indexing Management LLC purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth about $222,000. Norges Bank purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth about $27,739,000. UBS Group AG grew its holdings in shares of Prestige Consumer Healthcare by 377.6% during the fourth quarter. UBS Group AG now owns 131,382 shares of the company’s stock worth $8,043,000 after buying an additional 103,872 shares during the last quarter. Finally, Franklin Resources Inc. boosted its holdings in Prestige Consumer Healthcare by 9.6% in the 4th quarter. Franklin Resources Inc. now owns 20,057 shares of the company’s stock valued at $1,228,000 after purchasing an additional 1,764 shares in the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.